LipimetiX Development Inc
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From LipimetiX Development Inc
Digital Health Roundup: A Season For Interviews, New Frontiers, AI, Cybersecurity
In this roundup feature focusing on developments in digital health, Medtech Insight highlights interviews with Medtronic, Abbott and Congenica, partnerships and launches, and AI and cybersecurity announcements from November.
Point Of Care Diagnostics In 2022: New Technology But Old Problems
Following a busy year for point of care diagnostics, the industry is facing a period of consolidation. The drive for new technologies is being countered by regulatory and financial issues.
Congenica Tries To Bring Clarity To Personalized Medicine For Rare Diseases
Medtech Insight spoke to David Atkins, the CEO of genomics company Congenica, to learn more about how its platform is being used in one of the largest genetics studies to date. The company expects the technology to eventually transform treatment of rare diseases.
CIC Raises £150M To Reinforce Cambridge Ecosystem
Cambridge Innovation Capital completes £150m fundraising to give it more firepower to reinforce Cambridge, UK’s pre-eminent status as Europe’s leading life sciences and tech hub.
- Large Molecule
Drug Discovery Tools
- Other Names / Subsidiaries
- LipimetiX, LLC
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.